Millions of people have been impacted by Joint pain. It is one of the most common reasons that adults look for medical care. In fact, according to the Centers for Disease Control and Prevention (CDC), there are over 58 million adults who are living with doctor-diagnosed arthritis in the US alone. In addition to this, over 25 million people battle with daily limitations caused by joint pain. (CDC, 2024).
Probably, even more concerning, is the fact that an estimated 15 million adults experience severe joint pain rated seven or higher on a ten-point scale (Barbour et al., 2016).
Joint pain Causes
Joint pain is more than an inconvenience. It is something that limits mobility, affects sleep, reduces productivity, and significantly lowers quality of life. The real problem is that despite the impact that it has on people, treatments are often more focused on easing the discomfort, instead of fixing the biological problems that live inside the joints.
To inherit a deeper understanding as to why this happens, as well as where joint care is heading, we need to look at the pathology and anatomy of the joints to realize exactly how healing really works.
The Pathology of Joint Pain: A Slow Breakdown
Joint pain is not normally sudden. It develops over time and isn’t often caused by a single event. It is most often the result of repeated stress, bad movement patterns, inflammation, old injuries, or age-related tissue decline.
Small injuries start to accumulate when joints are overloaded, and it is these micro-injuries that start to trigger inflammation, which is meant to help the healing process. It is important to note that in the short term, inflammation is a good thing, as it increases blood flow, brings nutrients, and activates join repair.
The problem occurs when inflammation does not shut off.
Inflammation that becomes chronic actually damages tissue instead of repairing it. Because of this, cartilage thins, ligaments weaken, joint capsules stiffen, and tendons lose their elasticity. As time progresses, pain starts to become an everyday occurrence, and movements that were once easy become restricted.
It is this very process that explains why joint pain often starts again, even after we have rested, medicated or injected. The bottom line? The surface symptoms have been addressed, but the underlying tissue damage remains.
Joint Anatomy: Multiple Tissues, One Problem
Think of a joint as a living system made of several structures that must work together, and not merely bone meeting bone. Let’s elaborate:
- Cartilage is the cushioning in the joints that allow for smooth movement. When it has little blood supply, it heals very slowly.
- Ligaments are used to stabilize joints but unfortunately weaken when they have been injured or overstretched.
- Tendons connect muscle to bone and are extremely vulnerable to overuse.
- The joint capsule and synovium control joint nutrition and produce lubricating fluid.
- Bone beneath cartilage absorbs force and changes when cartilage is lost.
People who live with joint pain are most often affected when more than one of these tissues has been compromised. Unfortunately, treating pain without restoring tissue health does not work to restore joint function.
Why Most Creams Only Mask Pain
Products such as topical pain creams have become extremely popular as they offer fast relief and are easy to use. The problem is that these products only mask the pain and do nothing to heal tissue.
These products stimulate the nerve endings in the skin to create sensations such as cooling, warming, or tingling, but it is these very sensations that begin to compete with the pain signals that travel to the brain. In other words: when the brain is distracted, pain is reduced.
While these products offer short-term comfort, they do not work to repair cartilage, strengthen ligaments, or restore tissue that has already been damaged. In fact, masking pain without proper healing can become both problematic and risky.
Pain is there to serve as a warning signal, and when it goes away or eases without proper repair, people are quick to push their damaged joints, further accelerating their degeneration. It is clear: pain relief is not the same as healing.
Why Damaged Joint Tissue Stops Healing
Most people believe that joint tissue is “dead”, however, in reality, most joint tissue is inactive, but still very alive.
Cells in cartilage, ligaments, and tendons need biological signals to know when to:
- Reduce inflammation
- Produce collagen
- Rebuild structure
- Restore normal function
Cells enter a low-activity state when these signals are weak or missing, and healing either slows down or stops entirely. This is because the tissue is waiting for instructions that never come.
Healing Happens Through Signals
Healing is driven by cellular communication rather than tissue replacement, and modern regenerative science has proven that bioactive messages, or signals tell our cells how to behave. These signals significantly influence inflammation, repair activity, and tissue remodeling.
Bioactive biomolecules have gained much interest as they act as messengers rather than building blocks. They do not become tissue themselves but instead activate the body’s own repair systems.
One well-studied source of biological signaling comes from Wharton’s Jelly–derived mesenchymal signaling environments. These systems contain extracellular vesicles (EVs) that help cells communicate. EVs do not contain DNA and do not form tissue.
Their role is signaling, and research suggests that these signals can influence inflammation control, tissue repair pathways, and cellular activity. This is what makes them an attractive option for joint recovery.
The Problem: Science Without Regulation
The science that backs regenerative signaling is promising, but the industry has moved ahead of regulation, and the U.S. Food and Drug Administration (FDA) has clearly stated that no exosome or EV products are FDA-approved as drugs. This has, in turn, led to it issuing multiple warnings about misleading regenerative medicine claims (FDA, 2019; FDA, 2020).
Due to a limited oversight, products often vary widely in quality, racking up concerns of:
- Poor or unclear sourcing
- Inconsistent processing
- Degraded or inactive signaling molecules
- Contamination risks
- Claims that exceed available evidence
Scientific reviews have repeatedly called for stronger regulatory frameworks to ensure safety, consistency, and transparency in EV-based products (Wang et al., 2024).
The bottom line: patients are left to sort through confusing claims, damaging their trust in legitimate science when these regulations are weak.
A Safer Direction: Activation Without Hype
Many clinicians and researchers are looking for safer ways to activate tissue repair without having to rely on poorly regulated biologic products due to regulatory and sourcing concerns.
Interestingly, nature already provides signaling systems that interact with human biology, and there are certain plant-derived bioactive biomolecules that can engage with overlapping repair pathways. These are the very same pathways that are involve inflammation balance, cellular energy, and tissue response.
When they are properly formulated and responsibly sourced, these natural signaling systems offer:
- Better safety profiles
- More consistent sourcing
- Lower regulatory risk
- Improved accessibility
The goal is not to copy biology exactly, but to activate similar healing pathways in a safer, more controlled way.
The Science Is Ready but The Industry Is Not
The science of joint regeneration is real, but due to a lack of proper regulation, poor sourcing and exaggerated claims patient safety and public trust is diminished in a field that could genuinely help millions living with joint pain.
Joint pain is not just something to silence, it is a signal that tissue communication has failed. The future of joint care needs to move beyond masking the symptoms and demand transparency, responsible sourcing, and realistic claims grounded in biology. Because when we focus on restoring that communication, we can move from temporary relief to real healing.
References:
- Centers for Disease Control and Prevention (CDC). Arthritis Basics. Updated 2024.
- Barbour KE, et al. Prevalence of Severe Joint Pain Among Adults with Arthritis. MMWR, 2016.
- U.S. Food and Drug Administration (FDA). Public Safety Notification on Exosome Products. 2019.
- FDA. Consumer Alert on Regenerative Medicine Products. 2020.
- Wang CK, et al. Regulatory Challenges of Extracellular Vesicles as Biologic Medicines. 2024.
Be the first to comment